TapewireFind a company

person · Reporting owner

Francis Roger F.

Disclosed activity across 2 companies

Tapewire entity
69732
SEC CIK
0001857010

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
National Vision Holdings, Inc.EYE · Entity 1716SVP, Chief Stores OfficerMay 03, 2022May 05, 2022
SYSCO CORPSYY · Entity 2003SVPJanuary 01, 2026January 09, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

National Vision Holdings, Inc.

Report date May 03, 2022 · Filed May 05, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect3,804 Ending reported balance After 2022-05-03 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2022-05-03 · Exercise / conversion · Acquired 2,239 · Balance 4,478

F1: Each restricted stock unit represents a contingent right to receive one share of NVHI common stock.

Row 2 · 2022-05-03 · Tax withholding · Disposed 674 · Balance 3,804

F2: On May 3, 2022, 2,239 restricted stock units vested and 674 shares of the Company's common stock were withheld to satisfy tax withholding obligations. The closing price on May 3, 2022 of the Company's common stock on NASDAQ was $37.71 per share.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect10,307 Reported balance After 2022-05-03 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2022-05-03 · Exercise / conversion · Disposed 2,239 · Balance 10,307

F1: Each restricted stock unit represents a contingent right to receive one share of NVHI common stock.

F3: On May 3, 2021, the reporting person was granted 3,359 restricted stock units, which will vest in two installments, with 2,239 shares vesting on the first anniversary of the grant date and 1,120 shares vesting on the second anniversary of the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one share of NVHI common stock.

F2: On May 3, 2022, 2,239 restricted stock units vested and 674 shares of the Company's common stock were withheld to satisfy tax withholding obligations. The closing price on May 3, 2022 of the Company's common stock on NASDAQ was $37.71 per share.

F3: On May 3, 2021, the reporting person was granted 3,359 restricted stock units, which will vest in two installments, with 2,239 shares vesting on the first anniversary of the grant date and 1,120 shares vesting on the second anniversary of the grant date.

SYSCO CORP

Report date January 01, 2026 · Filed January 09, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect18,947.623 Reported balance Holding disclosure · report date 2026-01-01 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 18,947.623

Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $82.22 · Expires 2032-08-31DirectNot disclosed Reported balance Holding disclosure · report date 2026-01-01 · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · Balance Not disclosed

F1: Stock options granted on 09/01/2022 and became exercisable with respect to 33.3% of the total number of originally issued options on each of the first three anniversaries of the grant date.

Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $73.53 · Expires 2033-08-09DirectNot disclosed Reported balance Holding disclosure · report date 2026-01-01 · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · Balance Not disclosed

F2: Stock options granted on 08/10/2023 and become/became exercisable with respect to 33.3% of the total number of originally issued options on each of the first three anniversaries of the grant date.

Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $76.54 · Expires 2034-08-20DirectNot disclosed Reported balance Holding disclosure · report date 2026-01-01 · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · Balance Not disclosed

F3: Stock options granted on 08/21/2024 and become/became exercisable with respect to 33.3% of the total number of originally issued options on each of the first three anniversaries of the grant date.

Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $80.98 · Expires 2035-08-20DirectNot disclosed Reported balance Holding disclosure · report date 2026-01-01 · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · Balance Not disclosed

F4: Stock options granted on 08/21/2025 and become exercisable with respect to 33.3% of the total number of originally issued options on each of the first three anniversaries of the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: Stock options granted on 09/01/2022 and became exercisable with respect to 33.3% of the total number of originally issued options on each of the first three anniversaries of the grant date.

F2: Stock options granted on 08/10/2023 and become/became exercisable with respect to 33.3% of the total number of originally issued options on each of the first three anniversaries of the grant date.

F3: Stock options granted on 08/21/2024 and become/became exercisable with respect to 33.3% of the total number of originally issued options on each of the first three anniversaries of the grant date.

F4: Stock options granted on 08/21/2025 and become exercisable with respect to 33.3% of the total number of originally issued options on each of the first three anniversaries of the grant date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 03, 2022 Filed May 5, 2022 20:36 UTC National Vision Holdings, Inc. EYE · Entity 1716 Exercise / conversionRestricted Stock Units · Derivative 2,239 $0.00 $0.00
Disclosure

SEC source: 0001857010-22-000004 · wf-form4_165178296982991.xml · derivative · entry 3

Francis Roger F. · CIK 0001857010 · SVP, Chief Stores Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,307

Underlying: Common Stock · 2,239 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of NVHI common stock.

F3 · derivative.exercise_date: On May 3, 2021, the reporting person was granted 3,359 restricted stock units, which will vest in two installments, with 2,239 shares vesting on the first anniversary of the grant date and 1,120 shares vesting on the second anniversary of the grant date.

F3 · derivative.expiration_date: On May 3, 2021, the reporting person was granted 3,359 restricted stock units, which will vest in two installments, with 2,239 shares vesting on the first anniversary of the grant date and 1,120 shares vesting on the second anniversary of the grant date.

Read SEC document
May 03, 2022 Filed May 5, 2022 20:36 UTC National Vision Holdings, Inc. EYE · Entity 1716 Tax withholdingCommon Stock 674 Not disclosed Not disclosed
Disclosure

SEC source: 0001857010-22-000004 · wf-form4_165178296982991.xml · nonDerivative · entry 2

Francis Roger F. · CIK 0001857010 · SVP, Chief Stores Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,804

F2 · price: On May 3, 2022, 2,239 restricted stock units vested and 674 shares of the Company's common stock were withheld to satisfy tax withholding obligations. The closing price on May 3, 2022 of the Company's common stock on NASDAQ was $37.71 per share.

Read SEC document
May 03, 2022 Filed May 5, 2022 20:36 UTC National Vision Holdings, Inc. EYE · Entity 1716 Exercise / conversionCommon Stock 2,239 $0.00 $0.00
Disclosure

SEC source: 0001857010-22-000004 · wf-form4_165178296982991.xml · nonDerivative · entry 1

Francis Roger F. · CIK 0001857010 · SVP, Chief Stores Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,478

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of NVHI common stock.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 21:42 UTC National Vision Holdings, Inc. EYE · Entity 1716 GrantRestricted Stock Units · Derivative 9,187 $0.00 $0.00
Disclosure

SEC source: 0001857010-22-000002 · wf-form4_164643010095440.xml · derivative · entry 1

Francis Roger F. · CIK 0001857010 · SVP, Chief Stores Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,546

Underlying: Common Stock · 9,187 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of NVHI common stock.

F2 · derivative.exercise_date: The restricted stock units will vest in three equal annual installments beginning on the first anniversary of the grant date.

F2 · derivative.expiration_date: The restricted stock units will vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
May 03, 2021 Filed May 5, 2021 20:34 UTC National Vision Holdings, Inc. EYE · Entity 1716 GrantStock Option (Right to Buy) · Derivative 6,685 $0.00 Strike: $52.11 $0.00
Disclosure

SEC source: 0001857010-21-000004 · wf-form4_162024687453526.xml · derivative · entry 2

Francis Roger F. · CIK 0001857010 · SVP, Chief Stores Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,685

Underlying: Common Stock · 6,685 shares

Expires 2031-05-03

F3 · derivative.exercise_date: The option vests in three equal installments beginning on the first anniversary of the grant date.

Read SEC document
May 03, 2021 Filed May 5, 2021 20:34 UTC National Vision Holdings, Inc. EYE · Entity 1716 GrantRestricted Stock Units · Derivative 3,359 $0.00 $0.00
Disclosure

SEC source: 0001857010-21-000004 · wf-form4_162024687453526.xml · derivative · entry 1

Francis Roger F. · CIK 0001857010 · SVP, Chief Stores Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,359

Underlying: Common Stock · 3,359 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a continent right to receive one share of NVHI common stock.

F2 · derivative.exercise_date: The restricted stock units will vest in two installments, with 2,217 shares vesting on the first anniversary of the grant date and 1,142 shares vesting on the second anniversary of the grant date.

F2 · derivative.expiration_date: The restricted stock units will vest in two installments, with 2,217 shares vesting on the first anniversary of the grant date and 1,142 shares vesting on the second anniversary of the grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.